Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off. · 12 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 668 | $486.35 | $324,881.80 | filing |
| 2026-02-24 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,627 | $485.11 | $789,273.97 | filing |
| 2026-02-18 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 817 | $473.68 | $386,996.56 | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,031 | $489.46 | $994,093.26 | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,530 | $483.75 | $740,137.50 | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 4,962 | $0.00 | $0.00 | filing |
| 2026-02-13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,903 | $487.76 | $928,207.28 | filing |
| 2026-02-11 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 1,751 | $460.43 | $806,212.93 | filing |
| 2026-02-10 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 872 | $468.41 | $408,453.52 | filing |
| 2026-01-22 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 3,934 | $0.00 | $0.00 | filing |
| 2026-01-22 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 3,883 | $0.00 | $0.00 | filing |
| 2025-11-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,500 | $434.58 | $1.1M | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.